Sleep disorder study could pave way for Parkinson's prevention
NCT ID NCT05826457
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study enrolls 500 adults with a sleep condition called REM sleep behavior disorder (RBD), which often leads to Parkinson's disease or related brain disorders. Researchers will track symptoms like thinking, movement, and smell to develop a rating scale. The goal is to prepare for future clinical trials of treatments that might protect the brain.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study will provide the tools and knowledge needed to run future trials of treatments that might slow or stop Parkinson's and related diseases.
What could go wrong
This is an observational study, not a treatment trial. It does not test any drug or therapy, so there is no direct benefit to participants. The results may not lead to a successful treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Emory University
Atlanta, Georgia, 30322, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02145, United States
-
Mayo Clinic Rochester
Rochester, Minnesota, 55905, United States
-
McGill University Health Centre Research Institute
Montreal, Quebec, H4A 3J1, Canada
-
Oregon Health Sciences University
Portland, Oregon, 97239, United States
-
Stanford University
Redwood City, California, 94063, United States
-
University of California Los Angeles
Los Angeles, California, 90095, United States
-
University of Minnesota
Minneapolis, Minnesota, 55414, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States